Multimedia

Potential Upswing in Tick-borne Infections Predicted

Potential Upswing in Tick-borne Infections Predicted

Lyme Disease is the most common tick-borne illness.

Recreational Running Is Beneficial for Hip and Knee Health

Recreational Running Is Beneficial for Hip and Knee Health

A recent study is providing evidence that recreational running is beneficial for hip and knee joint health.

Lupus Severity, Treatment Affected By Socioeconomic Disparities

Lupus Severity, Treatment Affected By Socioeconomic Disparities

Socioeconomic and racial disparities are linked in the severity and treatment of lupus.

Ultrasounds a Better Imaging Choice for Broken Arms in Children

Ultrasounds a Better Imaging Choice for Broken Arms in Children

Ultrasound imaging is more accurate, faster, and less painful than traditional X-rays for assessing the broken arms of children.

Rheumatoid Arthritis Clinical Guidelines Quiz

Compete against your peers with our rheumatoid arthritis clinical quiz.

Ankylosing Spondylitis and Axial Spondyloarthritis Treatment Recommendations: A Clinical Practice Assessment

Compete against your peers with our ankylosing spondylitis/nonradiographic axial spondyloarthritis clinical quiz.

Alcohol Use: Surveying Effects on the Body's Major Systems

The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored.

Influence of the Microbiome in Spondyloarthritis

While studies on the effect of the gut microbiome on spondyloarthritis are limited, new research and technology are poised to expand future microbiome-directed arthritis treatments.

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general population. Despite the growing recognition of CVD as a common complication of RA, many rheumatologists do not aggressively manage CV risk in patients with rheumatic disease.

VIDEO: Updated Clinical Trial Results for Abaloparatide

VIDEO: Updated Clinical Trial Results for Abaloparatide

Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.

Efficacy of Open-Label Tocilizumab in Early Systemic Sclerosis

Efficacy of Open-Label Tocilizumab in Early Systemic Sclerosis

Dinesh Khanna, MD, MSc, discusses results of the open-label portion of a trial evaluating the safety and efficacy of placebo-treated patients with systemic sclerosis who were switched to received open-label tocilizumab.

Phase 3 GiACTA Trial Results for TCZ in Giant Cell Arteritis

Phase 3 GiACTA Trial Results for TCZ in Giant Cell Arteritis

John H. Stone, MD, MPH, discusses results from a phase 3, double-blind, randomized, controlled trial evaluating the efficacy of tocilizumab for the treatment of giant cell arteritis.

Evaluating Efficacy of Sarilumab vs Adalimumab Monotherapy in RA

Evaluating Efficacy of Sarilumab vs Adalimumab Monotherapy in RA

Gerd Burmester, MD,discusses results from the SARIL-RA-MONARCH trial.

Emerging Research in Pediatric Localized Scleroderma

Emerging Research in Pediatric Localized Scleroderma

Sarah Taber, MD, briefly reviews her ongoing research on genetic drivers of localized scleroderma in pediatric patients.

Pooled Safety Data Available for Lesinurad in Gout

Pooled Safety Data Available for Lesinurad in Gout

Kenneth Saag, MD, discusses new pooled safety data for lesinurad for the treatment of gout.

Reducing Glucocorticoid Exposure in ANCA-Associated Vasculitis

Reducing Glucocorticoid Exposure in ANCA-Associated Vasculitis

Researchers suggest that relapsing MPA and GPA and increased BMI were associated with increased glucocorticoid exposure following induction of remission.

Mitigating ILD-Related Morbidity in Rheumatoid Arthritis

Mitigating ILD-Related Morbidity in Rheumatoid Arthritis

Eric L. Matteson, MD, MPH, sat down with Rheumatology Advisor to discuss the morbidity associated with interstitial lung disease in RA.

Expanded Osteoporosis Treatment Options on the Horizon

Expanded Osteoporosis Treatment Options on the Horizon

Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.

Sign Up for Free e-newsletters